Literature DB >> 33073521

Challenges of long-term vascular access in pediatric hemodialysis: Recommendations for practitioners.

Rupesh Raina1,2, Hirva Joshi3, Ronith Chakraborty1, Sidharth Kumar Sethi4.   

Abstract

Kidney transplantation is the preferred treatment of end-stage renal disease in children. However, time to transplant varies, making a well-functioning long-term vascular access essential for performing hemodialysis efficiently and without disruption until a kidney becomes available. However, establishing long-term vascular access in pediatric patients can present distinct challenges due to this population's unique characteristics, such as smaller body size and lower-diameter blood vessels. There are three main pediatric long-term vascular access options, which include central venous catheters (CVC), arteriovenous fistula (AVF), and arteriovenous graft (AVG). CVC are currently the most widely used modality, although various studies and guidelines recommend AVF or AVG as the preferred option. Although AVF should be used whenever possible, it is crucial that clinicians consider factors such as patient size, physical exam findings, comorbidities, predicted duration of treatment to decide on the most optimal long-term vascular access modality. This article reviews the three long-term vascular access methods in children and the benefits and complications of each.
© 2020 International Society for Hemodialysis.

Entities:  

Keywords:  Pediatrics; arteriovenous grafts; central venous catheter; hemodialysis; vascular access

Year:  2020        PMID: 33073521     DOI: 10.1111/hdi.12868

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  1 in total

1.  Analysis of Different Vascular Accesses on Dialysis Quality and Infection Risk Factors of Hemodialysis Patients.

Authors:  Huaping Wu; Xiang Li; Cunliang Zeng; Li Zhang; Huanhuan Song; Kaiping Lv
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-26       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.